Skip to content
Life Sciences Series A Founded 2016

Mantra Bio

Developer of exosomes to deliver safe, highly targeted medicines. The company has developed REVEAL, an exosome engineering platform combining computational biology and lab automation to generate targeted exosome vehicles (TEVs) for a broad set of therapeutic areas. The company was founded in 2016 and headquartered in San Francisco, United States. It has raised $44.1M in series a funding, with backing from Samsung…

📍 San Francisco, United States · Genomics,

Funding snapshot

Last roundSeries A
Amount$9M
Date4 January 2023
Total raised$44M
Team size7

About

Developer of exosomes to deliver safe, highly targeted medicines. The company has developed REVEAL, an exosome engineering platform combining computational biology and lab automation to generate targeted exosome vehicles (TEVs) for a broad set of therapeutic areas. The company was founded in 2016 and headquartered in San Francisco, United States. It has raised $44.1M in series a funding, with backing from Samsung Securities, 8VC, Viking Global Investors, Illumina, and others. The company operates in the Life Sciences - Genomics, Life Sciences - Clinical Genomics, Life Sciences - Drug Delivery space. The company's offerings encompass Drug Delivery - Extracellular Vesicles Based - Exosome Based, Genomics - Applied Genomics - Clinical Genomics - Therapeutics.

Business model

Drug Delivery > Extracellular Vesicles Based > Exosome Based,

Genomics > Applied Genomics > Clinical Genomics > Therapeutics

Institutional investors

Samsung Securities 8VC Viking Global Investors Illumina BoxGroup Allen & Company Springboard Enterprises

Latest coverage

No articles yet.

Raising like Mantra Bio?

Analyze your pitch deck before your next raise.

Analyze My Deck →